Member Info for sphinx100

2. (EP3534725) WATER SOLUBLE TOMATO EXTRACT PROTECTS AGAINST ADVERSE EFFECTS OF AIR POLLUTION

National Biblio. DataDocuments
PermaLink
PermaLink
Bookmark
Office : European Patent Office
Application Number: 17803808 Application Date: 02.11.2017
Publication Number: 3534725 Publication Date: 11.09.2019
Publication Kind : A1
Designated States: AL, AT, BA, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Prior PCT appl.: Application Number:EP2017077993 ; Publication Number: Click to see the data
IPC:
A23L 33/105
A61K 36/81
CPC:
A23L 33/105
A23V 2002/00
A61K 36/81
Applicants: PROVEXIS NATURAL PRODUCTS LTD
Inventors: MUSSLER BERND
RAEDERSTORFF DANIEL
RICHARD NATHALIE
Priority Data: 16196794 02.11.2016 EP
2017077993 02.11.2017 EP
Title: (DE) WASSERLÖSLICHER TOMATENEXKTRAKTSCHUTZ GEGEN NACHTEILIGE AUSWIRKUNGEN VON LUFTVERSCHMUTZUNG
(EN) WATER SOLUBLE TOMATO EXTRACT PROTECTS AGAINST ADVERSE EFFECTS OF AIR POLLUTION
(FR) UTILISATION D'UN EXTRAIT DE TOMATE HYDROSOLUBLE POUR LA PROTECTION CONTRE LES EFFETS NÉFASTES DE LA POLLUTION ATMOSPHÉRIQUE
Abstract:
(EN) The present invention relates to compositions comprising a water soluble tomato extract (WSTE) which may be used in maintaining cardiovascular health, lessening the risk of developing cardiovascular health problems, or reducing the likelihood of worsening an existing cardiovascular health problem in a subject exposed, or is at risk of exposure, to particulate air pollution.
(FR) La présente invention concerne des compositions comprenant un extrait de tomate hydrosoluble (WSTE) qui peut être utilisé pour maintenir la santé cardiovasculaire, diminuer le risque de développer des problèmes de santé cardiovasculaire, ou réduire la probabilité d'aggraver un problème de santé cardiovasculaire existant chez un sujet exposé, ou à risque d'être exposé, à la pollution atmosphérique particulaire.

CB. DEFINITION of Close Period
The close period is the time period between the completion of a listed company's financial results and the announcing of these results to the public. The close period is typically regarded as the one-month period preceding the release of a company's quarterly results, and the two-month period before the release of its annual results.

And remember he knows what’s coming for pxs

Always welcome directors using their own money to support the company

https://www.dsm.com/markets/human-nutrition/en/talking-nutrition/fueling-team-sunweb-cycling-team.html?utm_source=adobe-campaign&utm_medium=email&utm_campaign=hnh-issue-6&utm_term=subscribers-na&utm_content=team-sunweb&utm_vehicle=dsm-newsletter&deliveryName=DM4666

Ok just read it ,nice work if you can get it

Can’t read the RNS but it’s the award of share options

Looks like they have enough cash for 6 months , a lot could happen in that time ! ......................"Based on its current level of cash it is expected that the Group will need to raise further equity finance in the coming six months,“

Thanks Gixer another great find , looks like it’s called “Yiluotong” if I’m reading it right .

Unfortunately will have to wait another 6 months for full year results ,not looking good

With this sort of revenue I feel the valuation has further to fall , opti need £3-4 million profit to justify a £45 m market cap

Hi GccRa. I think if you look back over Bella’s post it will give an answer to your question , basically we get £3.22p for each packet sold , that factor has proved to be fairly accurate over the last couple of years , with bella’s latest factor reducing to £3.10 p

Hi Bella , thanks for the reply and as I thought you were not that far off , on that H2 number it looks like the multiplier will drop to about 3.00. So at least we have some idea about income from that source, I will carry on using that until someone else comes up with something better ,which I doubt will happen , this will all be blown away if we get Blue Hat of course . When you read the last Rns closely it appears to me that they have orders waiting on blue hat approval , imo they have several orders with each order having value of multiples of today’s turnover ,so it must be in the £millions . Would value your opinion on this as I have been known to be wrong in the past .

Bella looks like someone is buying under the radar ! By the way how did your prediction for ff+ sales measure up ?

Will be interesting to see what the outlook is and Q1 trading ,only a month to wait

From the trading update , does anyone understand the direct brand model , I believe Herbalife are huge in this area , “. The Company is seeking to expand further its commercial activities with Fruitflow+ Omega-3 and other Fruitflow+ combination products, and it is currently in dialogue with some potential direct brand owner customers.”

From al the information i’ve Been reading over the last few days it seems that ‘Blue hat ‘ is the gold standard in Chinese retail , it is respected by all consumers in China and is almost a licence to print money , let’s hope we can achieve it , but also other opportunities are being persued around the globe and I would’nt be surprised if we heard some news from Another country . Imho

Kiev which product is that ?I wonder how they’re doing with the probiotic products they bought last year !

Gixer I see what you mean , I make it about 28 weeks from submission ,and of course the EFSA submission would have covered a lot of the requirements for Samr , they are very similar in their requirements , could happen quite quickly but wtfdik

Timelines http://www.cirs-reach.com/news-and-articles/Timeline-and-Budget-for-Health-Food-Access-to-the-Chinese-Market.html